These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1061 related articles for article (PubMed ID: 2568044)

  • 1. Adenylate cyclase activity in homogenates of human melanoma cells. Effect of alpha-MSH and isoprenaline.
    Karg E; Johansson LH; Hindemith-Augustsson A; Rosengren E; Rorsman H
    Acta Derm Venereol; 1989; 69(4):288-91. PubMed ID: 2568044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of choroid plexus peptide IIF on adenylate cyclase and 3',5'-cyclic adenosine monophosphate in adipose tissue.
    Rudman D
    J Pharmacol Exp Ther; 1975 Dec; 195(3):532-9. PubMed ID: 172624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large potentiation of agonist response in intact cells is produced by increases only in GTP-dependent adenylate cyclase activity.
    Johnson GS; Kimura N; Kimura N
    J Cyclic Nucleotide Res; 1981; 7(2):105-15. PubMed ID: 6278002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal activation of adenylate cyclase in mouse melanoma metastatic variants.
    Niles RM; Makarski JS
    J Cell Physiol; 1978 Sep; 96(3):355-9. PubMed ID: 209054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forskolin stimulates adenylate cyclase activity, adenosine 3',5'-monophosphate production and peptide release from the intermediate lobe of the rat pituitary gland.
    Miyazaki K; Goldman ME; Kebabian JW
    Endocrinology; 1984 Mar; 114(3):761-6. PubMed ID: 6321138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular mechanisms of regulatory action of adrenergic receptor agonists on functional activity of adenylyl cyclase signaling system of the ciliates Dileptus anser and Tetrahymena pyriformis].
    Shpakov AO; Derkach KV; Uspenskaia ZI; Shpakova EA; Kuznetsova LA; Plesneva SA; Pertseva MN
    Tsitologiia; 2004; 46(4):317-25. PubMed ID: 15346790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance of whole cell isoproterenol and forskolin responsiveness in adenylate cyclase of permeabilized cells.
    Brooker G; Pedone C
    J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(2):113-21. PubMed ID: 3734226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha-Melanocyte-stimulating hormone binding and biological activity in a human melanoma cell line.
    Legros F; Coel J; Doyen A; Hanson P; Van Tieghem N; Vercammen-Grandjean A; Fruhling J; Lejeune FJ
    Cancer Res; 1981 Apr; 41(4):1539-44. PubMed ID: 6260342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ethanol in vitro on the beta adrenergic receptor-coupled adenylate cyclase system.
    Bode DC; Molinoff PB
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1040-7. PubMed ID: 2843625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha tocopheryl succinate inhibits melanocyte-stimulating hormone (MSH)-sensitive adenylate cyclase activity in melanoma cells.
    Sahu SN; Edwards-Prasad J; Prasad KN
    J Cell Physiol; 1987 Dec; 133(3):585-9. PubMed ID: 3693413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of high-affinity binding sites for beta-adrenergic blockers and lack of adenyl cyclase stimulation to beta-adrenergic stimulators in most normal and adenomatous human thyroid tissues.
    Goretzki PE; Wahl RA; Branscheid D; Roeher HD
    Surgery; 1984 Dec; 96(6):1001-8. PubMed ID: 6150553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic evidence for 5-HT1A receptors associated with human retinal pigment epithelial cells in culture.
    Nash MS; Osborne NN
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):510-9. PubMed ID: 9040484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of a variant of B16-mouse melanoma resistant to MSH growth inhibition.
    Niles RM; Logue MP
    J Supramol Struct; 1979; 11(2):251-8. PubMed ID: 232892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterologous sensitization of recombinant adenylate cyclases by activation of D(2) dopamine receptors.
    Cumbay MG; Watts VJ
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1201-9. PubMed ID: 11356947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The new positive inotrope sulmazole inhibits the function of guanine nucleotide regulatory proteins by affecting GTP turnover.
    Ramkumar V; Stiles GL
    Mol Pharmacol; 1988 Dec; 34(6):761-8. PubMed ID: 2849044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desensitization in rat parotid to beta-adrenergic agonists and counteracting effects of forskolin are conserved in membrane and detergent-solubilized adenylate cyclase catalyst activity.
    Harper JF
    J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(3):167-76. PubMed ID: 2876014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decay of hormone responsiveness in mouse melanoma cells in culture as a function of cell density.
    Fuller BB; Lebowitz J
    J Cell Physiol; 1980 May; 103(2):279-87. PubMed ID: 6254996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The hormone-sensitive adenylyl cyclase system of the ciliate Dileptus anser].
    Derkach KV; Shpakov AO; Kuznetsova LA; Plesneva SA; Uspenskaia ZI; Pertseva MN
    Tsitologiia; 2002; 44(11):1129-33. PubMed ID: 12561735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Melanocyte-stimulating hormone induces growth of human malignant melanoma amelanotic cells with a change in cAMP, phosphatidylinositols, and inositol phosphate concentration].
    Sukhanov VA; Voronkova IM; Shvets SV; Morozova LF
    Biokhimiia; 1993 Feb; 58(2):211-23. PubMed ID: 8387347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of prostaglandin E1 on the cyclic adenosine-3',5'--monophosphate system and radiosensitivity of B-82 cells cultured in vitro].
    Malatsidze MA; Serobian GA; Chirkov IuIu; Sobolev AS
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1984; (9):33-7. PubMed ID: 6093900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.